• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Bleichroeder Acquisition Corp. I

    8/12/25 5:50:58 PM ET
    $BACQ
    Get the next $BACQ alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    BLEICHROEDER ACQUISITION COR

    (Name of Issuer)


    COMMON-STOCK

    (Title of Class of Securities)


    G1169T104

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G1169T104


    1Names of Reporting Persons

    Barclays PLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED KINGDOM
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,265,821.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,265,821.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,313,263.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.98 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    BLEICHROEDER ACQUISITION COR
    (b)Address of issuer's principal executive offices:

    1345 Avenue of the America
    Item 2. 
    (a)Name of person filing:

    Barclays PLC
    (b)Address or principal business office or, if none, residence:

    1 Churchill Place, London - E14 5HP
    (c)Citizenship:

    X0
    (d)Title of class of securities:

    COMMON-STOCK
    (e)CUSIP No.:

    G1169T104
    Item 4.Ownership
    (a)Amount beneficially owned:

    1265821
    (b)Percent of class:

    4.98  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    1313263

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    1313263

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    Barclays Bank PLC, Barclays Capital Inc
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Barclays PLC
     
    Signature:Ramya Rao
    Name/Title:Director
    Date:08/12/2025
    Get the next $BACQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BACQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BACQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million

    Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV (NASDAQ:BACQ) ("Inflection Point") today announced a significant increase to their previously disclosed private investment in public equity ("PIPE"). The increase comes from both new investors and existing investors increasing their commitments, bringing total PIPE commitments to more than $200 million, of which over $85 million has already been funded. This represents a substantial increase from t

    11/17/25 9:00:00 AM ET
    $BACQ

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

    Carrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers, today appointed Ryan Carrithers as its new Chief Financial Officer. Carrithers joins Merlin at a pivotal moment as the company prepares to go public in a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). In this role, he will oversee all of Merlin's financial operations and strategy, investor relations, M&A or strategic partnerships that support its autonomy road

    11/4/25 9:00:00 AM ET
    $ASTR
    $BACQ
    $DNA
    Transportation Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BACQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Folino Robert

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:19 PM ET
    $BACQ

    SEC Form 3 filed by new insider Shannon Kevin George

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:21 PM ET
    $BACQ

    SEC Form 3 filed by new insider Blitzer Michael

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:22 PM ET
    $BACQ

    $BACQ
    SEC Filings

    View All

    SEC Form S-4 filed by Inflection Point Acquisition Corp. IV

    S-4 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Filer)

    1/14/26 9:24:38 AM ET
    $BACQ

    Amendment: SEC Form SCHEDULE 13G/A filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G/A - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    12/5/25 2:59:08 PM ET
    $BACQ

    SEC Form 425 filed by Inflection Point Acquisition Corp. IV

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    12/3/25 8:42:42 AM ET
    $BACQ

    $BACQ
    Leadership Updates

    Live Leadership Updates

    View All

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

    Carrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers, today appointed Ryan Carrithers as its new Chief Financial Officer. Carrithers joins Merlin at a pivotal moment as the company prepares to go public in a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). In this role, he will oversee all of Merlin's financial operations and strategy, investor relations, M&A or strategic partnerships that support its autonomy road

    11/4/25 9:00:00 AM ET
    $ASTR
    $BACQ
    $DNA
    Transportation Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care